In this study, we performed an IGF axis–related gene signature study by pan-cancer analysis and stratified analysis of ccRCC patients by integrating multi-omics data, including molecular features, biological function, immune infiltration, and drug sensitivity analysis. Here, IGF1 is linked to nonpapillary renal cell carcinoma.